Episil Technologies Inc. AI Stock Analysis
Episil Technologies Inc. (3707) AI Stock Analysis
Episil Technologies Inc.
(TPEx:3707)
Episil Technologies scores near the bottom of the range. The dominant factor is a severe cyclical trough in its foundry operations: negative gross margin, a second consecutive year of widening net losses, and a fourth straight year of negative free cash flow as aggressive capital spending runs far ahead of near-collapsed operating cash flow. Technicals reinforce the caution, with the share price well below all major moving averages and a deeply negative MACD, although oversold RSI and stochastic readings suggest selling may be extended in the short term. Valuation provides no cushion given negative earnings and no dividend. The main mitigating factor is a conservative balance sheet - low 0.30 debt-to-equity, ongoing debt reduction and still-positive EBITDA - which buys time for a recovery, but until revenue and margins inflect the overall risk profile remains elevated.
Episil Technologies Inc. (3707) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 24.27B
- Dividend Yield
- ―
- Average Volume (3M)
- 10.04M
- Price to Earnings (P/E)
- -51.0
- Beta (1Y)
- 1.71
- Revenue Growth
- 22.70%
- EPS Growth
- 38.31%
- Country
- TW
- Employees
- 1,340
- Sector
- General
- Sector Strength
- 55
- Industry
- Semiconductors
Episil Technologies Inc. Business Overview & Revenue Model
Company Description
Episil Technologies Inc. is primarily involved in the research, development, production, and worldwide sales of advanced semiconductor products, including epitaxial wafers, silicon wafers, mixed-signal integrated circuits, and linear integrated circu...
Episil Technologies Inc. Financial Statement Overview
Summary
The weakest part of the story. Revenue has fallen three years running and sits roughly 35% below the 2022 peak, gross margin has collapsed from 19.5% to negative 3.3% (product is being sold below cost), and the net loss widened to about NT$757 million for a -13.1% net margin and -10.7% ROE. Cash generation is the most acute issue: operating cash flow nearly evaporated to about NT$20 million while heavy capex drove free cash flow to roughly negative NT$1.57 billion, the fourth consecutive year of negative FCF. The one genuine offset is a conservatively financed balance sheet - debt cut to NT$2.16 billion, debt-to-equity of just 0.30, and equity funding over half of assets - plus still-positive EBITDA, indicating losses are largely depreciation-driven. That cushion is shrinking, however, as accumulated losses erode equity.
Income Statement
19Very NegativeBalance Sheet
61PositiveCash Flow
16Very Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.43B | 5.77B | 5.82B | 7.08B | 8.88B | 7.27B |
| Gross Profit | 220.51M | -190.45M | 42.10M | 809.48M | 1.74B | 989.92M |
| EBITDA | 501.75M | 142.70M | 387.69M | 931.25M | 1.96B | 1.17B |
| Net Income | -591.58M | -757.49M | -525.29M | 67.07M | 821.00M | 232.03M |
Balance Sheet | ||||||
| Total Assets | 14.84B | 12.88B | 13.91B | 11.79B | 12.85B | 9.88B |
| Cash, Cash Equivalents and Short-Term Investments | 4.11B | 4.02B | 5.71B | 3.53B | 4.73B | 2.80B |
| Total Debt | 1.96B | 2.16B | 2.61B | 2.31B | 2.23B | 1.33B |
| Total Liabilities | 3.67B | 3.71B | 4.29B | 4.22B | 4.86B | 3.51B |
| Stockholders Equity | 8.72B | 7.10B | 7.52B | 5.53B | 5.77B | 4.47B |
Cash Flow | ||||||
| Free Cash Flow | -1.09B | -1.57B | -1.07B | -705.39M | 562.73M | 691.67M |
| Operating Cash Flow | 393.88M | 20.11M | 336.12M | 760.38M | 1.72B | 1.02B |
| Investing Cash Flow | -831.91M | -1.40B | -907.56M | -1.44B | -752.38M | -713.55M |
| Financing Cash Flow | 145.06M | -158.39M | 2.58B | -519.07M | 1.36B | 511.28M |
Episil Technologies Inc. Peers Comparison
Overall Rating
TW:813165Neutral
TW:808663Neutral
TW:326558Neutral
TW:232956Neutral
TW:811051Neutral
TW:370738Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 65Neutral | TWD 23.84B | 13.29 | ― | 1.86% | 37.20% | 416.69% | |
| 63Neutral | TWD 19.63B | 18.62 | ― | 1.68% | 38.98% | 147.17% | |
| 58Neutral | TWD 21.46B | 22.56 | ― | 2.60% | 15.38% | 34.04% | |
| 56Neutral | TWD 24.47B | 14.80 | ― | 2.68% | 10.61% | 51.02% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 51Neutral | TWD 18.96B | 10.01 | ― | 4.00% | 11.36% | 213.16% | |
| 38Underperform | TWD 24.11B | -51.01 | ― | ― | 22.70% | 38.31% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:3707 | Episil Technologies Inc. | 60.20 | 9.80 | 19.44% | |
| TW:2329 | Orient Semiconductor Electronics, Limited | 37.30 | -14.60 | -28.13% | |
| TW:3265 | Winstek Semiconductor Co. Ltd. | 157.50 | 60.56 | 62.46% | |
| TW:8086 | Advanced Wireless Semiconductor Co. | 99.90 | -15.43 | -13.38% | |
| TW:8110 | Walton Advanced Engineering, Inc. | 37.35 | -3.52 | -8.62% | |
| TW:8131 | Formosa Advanced Technologies Co., Ltd. | 53.90 | 6.24 | 13.10% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
